ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

7,36
-0,07
(-0,94%)
Geschlossen 27 September 10:00PM
7,36
0,00
( 0,00% )
Vor Marktöffnung: 11:48AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
7,36
Gebot
6,28
Fragen
11,70
Volumen
-
0,00 Tagesbereich 0,00
5,15 52-Wochen-Bereich 13,03
Marktkapitalisierung
Handelsende
7,36
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
914.142
Ausgegebene Aktien
107.144.465
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,75
Gewinn pro Aktie (EPS)
-0,95
Erlöse
36,53M
Nettogewinn
-101,74M

Über Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was US$7,36. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 5,15 to US$ 13,03.

Tango Therapeutics currently has 107.144.465 shares in issue. The market capitalisation of Tango Therapeutics is US$788,58 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -7.75.

TNGX Neueste Nachrichten

Tango Therapeutics to Participate in Upcoming Investor Conferences

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

– Dose expansion ongoing in TNG908 and TNG462 phase 1/2 clinical trials; comprehensive clinical data update for the PRMT5 program expected in 2H 2024 – – Patient enrollment is ongoing in TNG260...

Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program PR Newswire STOCKHOLM, May 23, 2024 STOCKHOLM, May 23, 2024 /PRNewswire/ -- Medivir AB (Nasdaq...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.08-12.79620853088.448.587.2812340467.82550733CS
4-3.78-33.931777378811.1411.927.2813614709.17328432CS
12-0.95-11.4320096278.3112.0157.289141429.49619297CS
26-0.17-2.257636122187.5312.0156.467607198.82664839CS
52-3.71-33.514001806711.0713.035.158387539.11855141CS
156-6.06-45.156482861413.4214.962.475680848.06889439CS
260-2.25-23.41311134249.6118.842.475571168.223618CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DUOFangDD Network Group Ltd
US$ 1,67
(56,07%)
13,16M
ONCOOnconetix Inc
US$ 4,82
(43,65%)
670,99k
RGFReal Good Food Company Inc
US$ 0,4985
(34,73%)
2,34M
ESTAEstablishment Labs Holdings Inc
US$ 52,71
(27,95%)
4,44k
CDIOCardio Diagnostics Holdings Inc
US$ 0,3138
(25,52%)
8,37M
HLPHongil Group Inc
US$ 0,905
(-49,86%)
9
AYTUAYTU BioPharma Inc
US$ 2,30
(-19,27%)
770
NVNOenVVeno Medical Corporation
US$ 3,73
(-17,11%)
10,38k
MNTSMomentus Inc
US$ 0,4499
(-16,06%)
139,67k
AIFFFirefly Neuroscience Inc
US$ 2,52
(-16,00%)
1,49k
XPONExpion360 Inc
US$ 0,0795
(23,45%)
25,89M
DUOFangDD Network Group Ltd
US$ 1,67
(56,07%)
13,16M
CDIOCardio Diagnostics Holdings Inc
US$ 0,3138
(25,52%)
8,37M
MTCMMTec Inc
US$ 0,3658
(9,69%)
2,42M
RGFReal Good Food Company Inc
US$ 0,4985
(34,73%)
2,34M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock